David Epstein
Founder at BLACK DIAMOND THERAPEUTICS, INC.
Net worth: 5 M $ as of 29/04/2024
David Epstein active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Director/Board Member | 31/08/2016 | - |
| Founder | 31/12/2013 | - | |
| Chief Executive Officer | 31/08/2016 | 14/09/2023 | |
| President | 31/08/2016 | 14/09/2023 |
Career history of David Epstein
Former positions of David Epstein
| Companies | Position | Start | End |
|---|---|---|---|
| METASTAT, INC. | Director/Board Member | 15/04/2013 | 31/03/2015 |
| Corporate Officer/Principal | 15/04/2013 | 31/03/2015 | |
| OSI PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 06/04/2010 | 30/03/2013 |
Archemix Corp.
 Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | Director/Board Member | - | - |
| Founder | 30/04/2001 | 31/12/2002 | |
| Corporate Officer/Principal | 30/04/2001 | 31/12/2002 | |
| Duke-NUS Graduate Medical School Singapore | Corporate Officer/Principal | - | - |
Training of David Epstein
| Lewis & Clark College (Oregon) | Undergraduate Degree |
| Brandeis University | Doctorate Degree |
Statistics
International
| United States | 7 |
| Singapore | 2 |
Operational
| Director/Board Member | 3 |
| Corporate Officer/Principal | 3 |
| Founder | 2 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
| Producer Manufacturing | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| METASTAT, INC. | Producer Manufacturing |
| BLACK DIAMOND THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
Archemix Corp.
Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | Commercial Services |
- Stock Market
- Insiders
- David Epstein
- Experience
